President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...

The European Union still wants a trade pact with the US, but the bloc said to be readying its counterattack as President ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will increase.

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

Johnson and Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as ...

US President Donald Trump's 200% tariff threat on the pharmaceutical industry is a "shock" that will reverberate through ...

Already late with carrying out his administration's prior threats around pharmaceutical tariffs, President Donald Trump has ...

Lutnick made the remarks in a CNBC interview, shortly after U.S. President Donald Trump said during a Cabinet meeting that ...

Targeting European allies won't fix any of our problems with China, or improve health care, writes Josh Steuterman.

Drugmaker Swedish Orphan Biovitrum AB’s Chief Executive Officer Guido Oelkers said he doesn’t think tariff threats on the ...